Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6409783 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL128419 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL130943 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL3425314 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL5987889 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL29409479 | 0.97 | AKR1B1 (0.42) | AKR1B1GAPDH | |
| Ammonia Solution, Strong SCHEMBL28822860 | 0.97 | AKR1B1 (0.42) | AKR1B1GAPDH | |
| SCHEMBL30664650 | 0.97 | AKR1B1 (0.42) | AKR1B1GAPDH | |
| Alcohol SCHEMBL28228654 | 0.93 | AKR1B1 (0.44) | AKR1B1GAPDH | |
| Phosphoric Acid SCHEMBL5790794 | 0.91 | AKR1B1 (0.37) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127925-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | HERCULES CAPITAL, INC. | 2025-04-24 | — | — | US | disclosed |
| US-12076418-B2 | Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo | ENGENE, INC. (CA) | 2024-09-03 | — | — | US | disclosed |
| CN-116745430-A | Production of oligosaccharides comprising LN3 as core structure in host cells | 因比奥斯公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-116249781-A | Production of biological products containing GlcNAc in cells | 因比奥斯公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-116057064-A | Method for preparing ascariase and related compounds thereof | 艾斯库瑞博生物科学公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-115135769-A | KDO-free production hosts for oligosaccharide synthesis | 因比奥斯公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-115087740-A | Production of glycosylation products in host cells | 因比奥斯公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20220249645-A1 | MODIFIED STRAIN OF SALMONELLA ENTERICA TYPHI | PROKARIUM LIMITED (GB) | 2022-08-11 | — | — | US | disclosed |
| US-20220133907-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | HERCULES CAPITAL, INC. | 2022-05-05 | — | — | US | disclosed |
| EP-3970697-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | Engene, Inc. (CA) | 2022-03-23 | — | — | EP | disclosed |
| WO-1999046387-A1 | BIOSYNTHETIC GENES FOR SPINOSYN INSECTICIDE PRODUCTION | DOW AGROSCIENCES LLC (US) | 1999-09-16 | — | — | WO | disclosed |
| EP-0904376-A2 | PROTEINS INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF O-ANTIGEN IN PSEUDOMONAS AERUGINOSA | University of Guelph (CA) | 1999-03-31 | — | — | EP | disclosed |
| US-5707817-A | TYVELOSE JOINED TO GLYCOSIDES LINKAGES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-01-13 | — | — | US | disclosed |
| US-5686256-A | TYVELOSE-CONTAINING DISACCHARIDE OR OLIGOSACCHARIDE BINDS WITH ANTIBODY TO FORM COMPLEX | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1997041234-A2 | PROTEINS INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF O-ANTIGEN IN $i(PSEUDOMONAS AERUGINOSA) | UNIVERSITY OF GUELPH (CA) | 1997-11-06 | — | — | WO | disclosed |
| EP-0682527-A4 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS. | UNIV COLORADO STATE RES FOUND (US) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996030044-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1996-10-03 | — | — | WO | disclosed |
| US-5541075-A | DISACCHARIDES, OLIGOSACCHARIDES | HESKA CORPORATION (US) | 1996-07-30 | — | — | US | disclosed |
| EP-0682527-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1995-11-22 | — | — | EP | disclosed |
| WO-1994017824-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1994-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127925-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | CSGALNACT1, CHI3L2, LNPEP | AKR1B1 3046/4885GAPDH 797/4885 |
| US-12076418-B2 | Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo | CSGALNACT1, CHI3L2, LNPEP | AKR1B1 3046/4885GAPDH 797/4885 |
| US-20220133907-A1 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | CSGALNACT1, CHI3L2, LNPEP | AKR1B1 3046/4885GAPDH 797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.